Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Gilson

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Health Technology Assessment (Winchester, England)|September 25, 2020
Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCTRichard Gilson, Diarmuid Nugent, Kate Bennett, et al.
HIV Medicine|November 18, 2021
Follicle-stimulating hormone in postmenopausal women living with HIV: a prevalence studyShema Tariq, Hajra Okhai, Abigail Severn, et al.
Health Technology Assessment (Winchester, England)|March 28, 2019
Sexual risk reduction interventions for patients attending sexual health clinics: a mixed-methods feasibility studyCarina King, Carrie Llewellyn, Maryam Shahmanesh, et al.
The International Journal on Drug Policy|January 25, 2021
Recreational drug use and use of drugs associated with chemsex among HIV-negative and HIV-positive heterosexual men and women attending sexual health and HIV clinics in EnglandAda R Miltz, Alison J Rodger, Janey Sewell, et al.
Sexually Transmitted Infections|June 15, 2023
Predictors of starting and stopping chemsex in men who have sex with men in England: findings from the AURAH2 prospective studyRobbie Hammond, Valentina Cambiano, Fiona C Lampe, et al.
Health Technology Assessment (Winchester, England)|May 5, 2021
Provision of the progestogen-only pill by community pharmacies as bridging contraception for women receiving emergency contraception: the Bridge-it RCTSharon T Cameron, Anna Glasier, Lisa McDaid, et al.
HIV Medicine|July 26, 2021
Menopausal status, age and management among women living with HIV in the UKHajra Okhai, Caroline A Sabin, Katharina Haag, et al.
The Journal of Infectious Diseases|March 4, 2014
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposureSophie Jose, Lisa Hamzah, Lucy J Campbell, et al.
Lancet (London, England)|November 15, 2020
Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trialSharon T Cameron, Anna Glasier, Lisa McDaid, et al.
Journal of Clinical Epidemiology|March 30, 2010
Data linkage reduces loss to follow-up in an observational HIV cohort studyTeresa Hill, Loveleen Bansi, Caroline Sabin, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Health Technology Assessment (Winchester, England)|September 25, 2020
Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCTRichard Gilson, Diarmuid Nugent, Kate Bennett, et al.
HIV Medicine|November 18, 2021
Follicle-stimulating hormone in postmenopausal women living with HIV: a prevalence studyShema Tariq, Hajra Okhai, Abigail Severn, et al.
Health Technology Assessment (Winchester, England)|March 28, 2019
Sexual risk reduction interventions for patients attending sexual health clinics: a mixed-methods feasibility studyCarina King, Carrie Llewellyn, Maryam Shahmanesh, et al.
The International Journal on Drug Policy|January 25, 2021
Recreational drug use and use of drugs associated with chemsex among HIV-negative and HIV-positive heterosexual men and women attending sexual health and HIV clinics in EnglandAda R Miltz, Alison J Rodger, Janey Sewell, et al.
Sexually Transmitted Infections|June 15, 2023
Predictors of starting and stopping chemsex in men who have sex with men in England: findings from the AURAH2 prospective studyRobbie Hammond, Valentina Cambiano, Fiona C Lampe, et al.
Health Technology Assessment (Winchester, England)|May 5, 2021
Provision of the progestogen-only pill by community pharmacies as bridging contraception for women receiving emergency contraception: the Bridge-it RCTSharon T Cameron, Anna Glasier, Lisa McDaid, et al.
HIV Medicine|July 26, 2021
Menopausal status, age and management among women living with HIV in the UKHajra Okhai, Caroline A Sabin, Katharina Haag, et al.
The Journal of Infectious Diseases|March 4, 2014
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposureSophie Jose, Lisa Hamzah, Lucy J Campbell, et al.
Lancet (London, England)|November 15, 2020
Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trialSharon T Cameron, Anna Glasier, Lisa McDaid, et al.
Journal of Clinical Epidemiology|March 30, 2010
Data linkage reduces loss to follow-up in an observational HIV cohort studyTeresa Hill, Loveleen Bansi, Caroline Sabin, et al.
Pageof 15